Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice
Pharmacological Reports · 2024-06 · 76 (3) · 504-518
DOI: 10.1007/s43440-024-00588-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Reports, online erschienen am 18.04.2024. Verfasst von Agnieszka Pałucha-Poniewiera und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, Kraków, 31-343, Poland. nfpaluch@cyf-kr.edu.…. Hauptthemen laut MEDLINE: Antidepressive Agents, Brain-Derived Neurotrophic Factor, Hindlimb Suspension, Ketamine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
BACKGROUND: Partial negative allosteric modulators (NAM) of the metabotropic glutamate 5 (mGlu5) receptor are an excellent alternative to full antagonists and NAMs because they retain therapeutic effects and have a much broader therapeutic window. Here, we investigated whether partial mGlu5 NAM, 2-(2-(3-methoxyphenyl)ethynyl)-5-methylpyridine (M-5MPEP), induced a fast and sustained antidepressant-like effect, characteristic of rapid-acting antidepressant drugs (RAADs) like ketamine, in mice. METHODS: A tail suspension test (TST) was used to investigate acute antidepressant-like effects. Sustained effects were studied 24 h after the four intraperitoneal (ip) administrations using the splash test, designed to measure apathy-like state, the sucrose preference test (SPT), reflecting anhedonia, and the TST. Western blot and ELISA techniques were used to measure brain-derived neurotrophic factor (BDNF) and selected protein levels. METHODS: A tail suspension test (TST) was used to investigate acute antidepressant-like effects. Sustained effects were studied 24 h after the four intraperitoneal (ip) administrations using the splash test, designed to measure apathy-like state, the sucrose preference test (SPT), reflecting anhedonia, and the TST. Western blot and ELISA techniques were used to measure brain-derived neurotrophic factor (BDNF) and selected protein levels. CONCLUSION: Partial mGlu5 receptor NAM, M-5MPEP, induced rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhanced (R)-ketamine action in mice, indicating both substances' convergent mechanisms of action and the possibility of their practical use in treating depression as RAAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, Kraków, 31-343, Poland. nfpaluch@cyf-kr.edu.pl.
- Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, Kraków, 31-343, Poland.
- Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, Kraków, 31-343, Poland.
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Pałucha-Poniewiera, A., Rafało-Ulińska, A., Santocki, M., Babii, Y., & Kaczorowska, K. (2024). Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice. Pharmacological Reports, 76(3), 504-518. https://doi.org/10.1007/s43440-024-00588-3
Vancouver
Pałucha-Poniewiera A, Rafało-Ulińska A, Santocki M, Babii Y, Kaczorowska K. Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice. Pharmacological Reports. 2024;76(3):504-518. doi:10.1007/s43440-024-00588-3
BibTeX
@article{PauchaPoniewiera2024,
author = {Pałucha-Poniewiera, Agnieszka and Rafało-Ulińska, Anna and Santocki, Michal and Babii, Yana and Kaczorowska, Katarzyna},
title = {Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice},
journal = {Pharmacological Reports},
year = {2024},
volume = {76},
number = {3},
pages = {504--518},
doi = {10.1007/s43440-024-00588-3}
}
EUVIMED